Cipher Pharmaceuticals Inc. (TSX:CPH)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Specialty Pharmaceuticals	50.45M	33.36M	21.16M	20.68M	21.94M
Specialty Pharmaceuticals Growth	51.22%	57.66%	2.36%	-5.78%	1.56%
Total	50.45M	33.36M	21.16M	20.68M	21.94M
Total Growth	51.22%	57.66%	2.36%	-5.78%	1.56%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Canada	16.91M	14.79M	12.68M	12.41M	11.41M
Canada Growth	14.31%	16.65%	2.21%	8.72%	28.80%
United States (U.S.)	33.54M	18.57M	8.48M	8.27M	10.53M
United States (U.S.) Growth	80.61%	118.94%	2.58%	-21.48%	-17.38%
Total	50.45M	33.36M	21.16M	20.68M	21.94M
Total Growth	51.22%	57.66%	2.36%	-5.78%	1.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 28, 2026

Data Sources Report a data error